Trabecular Meshwork Regeneration for Glaucoma Treatment Using Stem Cell-Derived Trophic Factors
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Glaucoma is one of the leading causes of irreversible blindness. Stem cell therapy has shown promise in the treatment of primary open-angle glaucoma in animal models. Stem cell-free therapy using stem cell-derived trophic factors might be in demand in patients with high-risk conditions or religious restrictions. In this chapter, we describe methods for trabecular meshwork stem cell (TMSC) cultivation, secretome harvesting, and protein isolation, as well as assays to ensure the health of TMSC post-secretome harvesting and for secretome periocular injection into mice for therapeutic purposes.
References
1.
Quigley H, Broman A
. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90(3):262-7.
PMC: 1856963.
DOI: 10.1136/bjo.2005.081224.
View
2.
Du Y, Roh D, Mann M, Funderburgh M, Funderburgh J, Schuman J
. Multipotent stem cells from trabecular meshwork become phagocytic TM cells. Invest Ophthalmol Vis Sci. 2012; 53(3):1566-75.
PMC: 3339918.
DOI: 10.1167/iovs.11-9134.
View
3.
Du Y, Yun H, Yang E, Schuman J
. Stem cells from trabecular meshwork home to TM tissue in vivo. Invest Ophthalmol Vis Sci. 2013; 54(2):1450-9.
PMC: 4604717.
DOI: 10.1167/iovs.12-11056.
View
4.
Yun H, Wang Y, Zhou Y, Wang K, Sun M, Stolz D
. Human stem cells home to and repair laser-damaged trabecular meshwork in a mouse model. Commun Biol. 2018; 1:216.
PMC: 6283842.
DOI: 10.1038/s42003-018-0227-z.
View
5.
Coulon S, Schuman J, Du Y, Bahrani Fard M, Ethier C, Stamer W
. A novel glaucoma approach: Stem cell regeneration of the trabecular meshwork. Prog Retin Eye Res. 2022; 90:101063.
PMC: 9464663.
DOI: 10.1016/j.preteyeres.2022.101063.
View